4//SEC Filing
Martin Christopher Nathan 4
Accession 0002097992-25-000005
CIK 0001710072other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 7:08 PM ET
Size
5.5 KB
Accession
0002097992-25-000005
Insider Transaction Report
Form 4
Martin Christopher Nathan
Director
Transactions
- Award
Stock Options (Right to buy)
2025-11-19+45,150→ 45,150 totalExercise: $22.34Exp: 2035-11-19→ Common Stock (45,150 underlying)
Footnotes (1)
- [F1]1/36th of the shares subject to the option vest each month beginning on December 19, 2025, subject to the Reporting Person continuing as a service provider through each vest date.
Documents
Issuer
Edgewise Therapeutics, Inc.
CIK 0001710072
Entity typeother
Related Parties
1- filerCIK 0002097992
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 7:08 PM ET
- Size
- 5.5 KB